Thomas E. Jenkins
Fundador en Elysium Therapeutics, Inc. .
Perfil
Thomas E.
Jenkins is the founder of Elysium Therapeutics, Inc. which is founded in 2013, where he holds the title of Chief Scientific Officer.
He also held the position of Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. In terms of education, Jenkins holds a doctorate from Stanford University and an undergraduate degree from the University of Akron.
Cargos activos de Thomas E. Jenkins
| Empresas | Cargo | Inicio |
|---|---|---|
Elysium Therapeutics, Inc.
 Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Fundador | 01/01/2013 |
Antiguos cargos conocidos de Thomas E. Jenkins.
| Empresas | Cargo | Fin |
|---|---|---|
Signature Therapeutics, Inc.
 Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Director Técnico/Científico/I+D | - |
Formación de Thomas E. Jenkins.
| University of Akron | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Health Technology |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas E. Jenkins